Researchers launch database to track safety of new pancreatic tumor treatment
NCT ID NCT04693754
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study creates a database to track how safe and effective a procedure called endoscopic ultrasound radiofrequency ablation (EUS RFA) is for treating tumors or swollen lymph nodes in the pancreas. About 100 people aged 14 and older who are already scheduled for this procedure will have their medical records reviewed for up to 10 years. No extra tests or visits are required beyond standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Indiana University Health University Hospital
Indianapolis, Indiana, 46202-5121, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a radiofrequency knife beat the stapler for safer pancreas surgery?
- New device aims to seal pancreas during robotic surgery, cutting leak risk
- Experimental drug hopes to boost chemo against tough pancreatic cancer
- Zapping pancreatic tumors without surgery: a safer approach?
- Blood test hunt for silent killer: 5,000 High-Risk volunteers sought
- New procedure could zap pancreatic cysts before they turn deadly